Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials.J Am Acad Dermatol. 2023 08; 89(2):423-425.JA
Links
MeSH
Pub Type(s)
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
37121476
Citation
Spencer, Riley K., et al. "Comparative Efficacy of Biologics and Oral Agents in Palmoplantar Psoriasis and Palmoplantar Pustulosis: a Systematic Review and Network Meta-analysis of Randomized Clinical Trials." Journal of the American Academy of Dermatology, vol. 89, no. 2, 2023, pp. 423-425.
Spencer RK, Jin JQ, Elhage KG, et al. Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials. J Am Acad Dermatol. 2023;89(2):423-425.
Spencer, R. K., Jin, J. Q., Elhage, K. G., Davis, M. S., Hakimi, M., Bhutani, T., & Liao, W. (2023). Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials. Journal of the American Academy of Dermatology, 89(2), 423-425. https://doi.org/10.1016/j.jaad.2023.04.043
Spencer RK, et al. Comparative Efficacy of Biologics and Oral Agents in Palmoplantar Psoriasis and Palmoplantar Pustulosis: a Systematic Review and Network Meta-analysis of Randomized Clinical Trials. J Am Acad Dermatol. 2023;89(2):423-425. PubMed PMID: 37121476.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials.
AU - Spencer,Riley K,
AU - Jin,Joy Q,
AU - Elhage,Kareem G,
AU - Davis,Mitchell S,
AU - Hakimi,Marwa,
AU - Bhutani,Tina,
AU - Liao,Wilson,
Y1 - 2023/04/29/
PY - 2023/01/18/received
PY - 2023/04/12/revised
PY - 2023/04/16/accepted
PY - 2023/7/18/medline
PY - 2023/5/1/pubmed
PY - 2023/4/30/entrez
KW - Otezla
KW - acitretin
KW - adalimumab
KW - apremilast
KW - bimekizumab
KW - cyclosporine
KW - etanercept
KW - feet
KW - guselkumab
KW - hands
KW - imsidolimab
KW - infliximab
KW - ixekizumab
KW - methotrexate
KW - network meta-analysis
KW - palmoplantar
KW - palms
KW - psoriasis
KW - pustulosis
KW - secukinumab
KW - soles
KW - spesolimab
KW - tofacitinib
KW - upadacitinib
KW - ustekinumab
SP - 423
EP - 425
JF - Journal of the American Academy of Dermatology
JO - J Am Acad Dermatol
VL - 89
IS - 2
SN - 1097-6787
UR - https://www.unboundmedicine.com/medline/citation/37121476/Comparative_efficacy_of_biologics_and_oral_agents_in_palmoplantar_psoriasis_and_palmoplantar_pustulosis:_A_systematic_review_and_network_meta_analysis_of_randomized_clinical_trials_
DB - PRIME
DP - Unbound Medicine
ER -